Choksi Asia Stock Price Today (NSE: 530427)
Fundamental Score
Choksi Asia Share Price Live NSE/BSE & Institutional Fundamental Analysis
Choksi Asia share price today is ₹110.20, up +0.00% on NSE/BSE as of 30 September 2025. Choksi Asia (530427) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹62.83 (Cr). The 52-week high for 530427 share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 18.75x, 530427 is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 10.41% and a debt-to-equity ratio of 0.08.
Choksi Asia Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Choksi Asia Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Research report currently being updated.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Choksi Asia Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 530427 across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Attractive Valuation (P/E: 18.75 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (107.69%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (57.84%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (18.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (49.77% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (49.77% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.89x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (71.15%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Margin Pressure Concerns (-1.19%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Negative Free Cash Flow (₹-4.84 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Choksi Asia Financial Statements
Comprehensive financial data for Choksi Asia including income statement, balance sheet and cash flow
About 530427 (Choksi Asia)
Choksi Asia (530427) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹62.83 (Cr). Choksi Asia has delivered a Return on Equity (ROE) of 10.41% and a ROCE of 13.20%. The debt-to-equity ratio stands at 0.08, reflecting the company's capital structure. Investors tracking 530427 share price can monitor key metrics including P/E ratio, promoter holding of 71.15%, and quarterly earnings growth.
Company Details
530427 Share Price: Frequently Asked Questions
What is the current share price of Choksi Asia (530427)?
As of 30 Sept 2025, 03:25 pm IST, Choksi Asia share price is ₹110.20. The 530427 stock has a market capitalisation of ₹62.83 (Cr) on NSE/BSE.
Is 530427 share price Overvalued or Undervalued?
530427 share price is currently trading at a P/E ratio of 18.75x, compared to the industry average of 47.87x. Based on this relative valuation, the Choksi Asia stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of 530427 share price?
The 52-week high of 530427 share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Choksi Asia share price?
Key factors influencing 530427 share price include quarterly earnings growth (Sales Growth: 57.84%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Choksi Asia a good stock for long-term investment?
Choksi Asia shows a 5-year Profit Growth of 49.77% and an ROE of 10.41%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.08 before investing in 530427 shares.
How does Choksi Asia compare with its industry peers?
Choksi Asia competes with major peers in the Medical Equipment & Supplies. Investors should compare 530427 share price P/E of 18.75x and ROE of 10.41% against the industry averages to determine competitive standing.
What is the P/E ratio of 530427 and what does it mean?
530427 share price has a P/E ratio of 18.75x compared to the industry average of 47.87x. Investors pay ₹19 for every ₹1 of annual earnings.
How is 530427 performing according to Bull Run's analysis?
530427 has a Bull Run fundamental score of 68.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does 530427 belong to?
530427 operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Choksi Asia share price.
What is Return on Equity (ROE) and why is it important for 530427?
530427 has an ROE of 10.41%, which shows decent profitability but room for improvement. ROE measures how efficiently Choksi Asia generates profits from shareholders capital.
How is 530427 debt-to-equity ratio and what does it indicate?
530427 has a debt-to-equity ratio of 0.08, which indicates conservative financing with low financial risk.
What is 530427 dividend yield and is it a good dividend stock?
530427 offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Choksi Asia shares.
How has 530427 share price grown over the past 5 years?
530427 has achieved 5-year growth rates of: Sales Growth 18.24%, Profit Growth 49.77%, and EPS Growth 49.77%.
What is the promoter holding in 530427 and why does it matter?
Promoters hold 71.15% of 530427 shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Choksi Asia.
What is 530427 market capitalisation category?
530427 has a market capitalisation of ₹63 crores, placing it in the Small-cap category.
How volatile is 530427 stock?
530427 has a beta of N/A. A beta > 1 suggests the Choksi Asia stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is 530427 operating profit margin trend?
530427 has a 5-year average Operating Profit Margin (OPM) of -1.19%, indicating the company's operational efficiency.
How is 530427 quarterly performance?
Recent quarterly performance shows Choksi Asia YoY Sales Growth of 57.84% and YoY Profit Growth of 107.69%.
What is the institutional holding pattern in 530427?
530427 has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Choksi Asia stock.